Myogenic commitment of human stem cells by myoblasts Co-culture: a static vs. a dynamic approach. Issue 1 (31st December 2022)
- Record Type:
- Journal Article
- Title:
- Myogenic commitment of human stem cells by myoblasts Co-culture: a static vs. a dynamic approach. Issue 1 (31st December 2022)
- Main Title:
- Myogenic commitment of human stem cells by myoblasts Co-culture: a static vs. a dynamic approach
- Authors:
- Scala, Pasqualina
Lovecchio, J.
Lamparelli, E.P
Vitolo, R.
Giudice, V.
Giordano, E.
Selleri, C.
Rehak, L.
Maffulli, N.
Della Porta, G. - Abstract:
- Abstract: An in-vitro model of human bone marrow mesenchymal stem cells ( h BM-MSCs) myogenic commitment by synergic effect of a differentiation media coupled with human primary skeletal myoblasts ( h SkMs) co-culture was developed adopting both conventional static co-seeding and perfused culture systems. Static co-seeding provided a notable outcome in terms of gene expression with a significant increase of Desmin (141-fold) and Myosin heavy chain II (MYH2, 32-fold) at day 21, clearly detected also by semi-quantitative immunofluorescence. Under perfusion conditions, myogenic induction ability of h SkMs on h BM-MSCs was exerted by paracrine effect with an excellent gene overexpression and immunofluorescence detection of MYH2 protein; furthermore, due to the dynamic cell culture in separate wells, western blot data were acquired confirming a successful cell commitment at day 14. A significant increase of anti-inflammatory cytokine gene expression, including IL-10 and IL-4 (15-fold and 11-fold, respectively) at day 14, with respect to the pro-inflammatory cytokines IL-12A (7-fold at day 21) and IL-1β (1.4-fold at day 7) was also detected during dynamic culture, confirming the immunomodulatory activity of h BM-MSCs along with commitment events. The present study opens interesting perspectives on the use of dynamic culture based on perfusion as a versatile tool to study myogenic events and paracrine cross-talk compared to the simple co-seeding static culture.
- Is Part Of:
- Artificial cells, nanomedicine, and biotechnology. Volume 50:Issue 1(2022)
- Journal:
- Artificial cells, nanomedicine, and biotechnology
- Issue:
- Volume 50:Issue 1(2022)
- Issue Display:
- Volume 50, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 50
- Issue:
- 1
- Issue Sort Value:
- 2022-0050-0001-0000
- Page Start:
- 49
- Page End:
- 58
- Publication Date:
- 2022-12-31
- Subjects:
- hBM-MSCs -- human myoblasts -- paracrine effect -- myogenic commitment -- perfusion bioreactor system
Artificial cells -- Periodicals
Nanotechnology -- Periodicals
Blood substitutes -- Periodicals
Tissue engineering -- Periodicals
Molecules -- Periodicals
Biotechnology -- Periodicals
615.39 - Journal URLs:
- http://informahealthcare.com/loi/abb?open=2012#id_2012 ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/21691401.2022.2039684 ↗
- Languages:
- English
- ISSNs:
- 2169-1401
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21106.xml